Michael B. Mason
Sr. VP & Pres., Lilly Diabetes, Eli Lilly and Company.
Companies
- Eli Lilly and CompanySr. VP & Pres., Lilly Diabetes Jan 9, 2020 to Feb 14, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY40,241 shares2$50.6M at $1,257.32Feb 14, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 10, 2023Granted 8,023 shares at $345.12 of Eli Lilly and Company2
- Feb 1, 2023Shares withheld for tax 2,935 shares at $344.15 of Eli Lilly and Company3
- Feb 1, 2023Exercised options 6,690 shares of Eli Lilly and Company3
- Feb 9, 2022Granted 2,612 shares at $243.27 of Eli Lilly and Company4
- Feb 8, 2021Granted 6,350 shares at $205.77 of Eli Lilly and Company5
- Sep 1, 2020Shares withheld for tax 2,735 shares at $148.39 of Eli Lilly and Company6
- Sep 1, 2020Exercised options 6,244 shares of Eli Lilly and Company6
- Feb 11, 2020Granted 5,785 shares at $144.25 of Eli Lilly and Company7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 3, 2023
- 4SEC EDGARForm 4 filed Feb 11, 2022
- 5SEC EDGARForm 4 filed Feb 10, 2021
- 6SEC EDGARForm 4 filed Sep 2, 2020
- 7SEC EDGARForm 4 filed Feb 13, 2020